{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:55:07Z","timestamp":1770677707545,"version":"3.49.0"},"reference-count":26,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.3892\/or.2015.4389","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T06:27:00Z","timestamp":1446532020000},"page":"307-317","source":"Crossref","is-referenced-by-count":52,"title":["Resolvin D1 and E1 alleviate the progress of hepatitis toward liver cancer in long-term concanavalin A-induced mice through inhibition of NF-\u03baB activity"],"prefix":"10.3892","volume":"35","author":[{"given":"HAOYU","family":"KUANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAOLI","family":"HUA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIANHUI","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RUI","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,11,3]]},"reference":[{"key":"key20180107211517_b1-or-35-01-0307","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4254\/wjh.v6.i9.632","article-title":"Liver involvement in systemic infection","volume":"6","author":"Minemura","year":"2014","journal-title":"World J Hepatol"},{"key":"key20180107211517_b2-or-35-01-0307","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/liv.12573","article-title":"Hepatic progenitor cells in liver regeneration: Current advances and clinical perspectives","volume":"34","author":"Katoonizadeh","year":"2014","journal-title":"Liver Int"},{"key":"key20180107211517_b3-or-35-01-0307","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","article-title":"Autoimmune liver disease, autoimmunity and liver transplantation","volume":"60","author":"Carbone","year":"2014","journal-title":"J Hepatol"},{"key":"key20180107211517_b4-or-35-01-0307","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4254\/wjh.v7.i7.993","article-title":"Acute kidney injury in patients with chronic liver disease","volume":"7","author":"Rognant","year":"2015","journal-title":"World J Hepatol"},{"key":"key20180107211517_b5-or-35-01-0307","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/07853890.2014.934275","article-title":"A review of melatonin in hepatic ischemia\/reperfusion injury and clinical liver disease","volume":"46","author":"Li","year":"2014","journal-title":"Ann Med"},{"key":"key20180107211517_b6-or-35-01-0307","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.imbio.2014.09.018","article-title":"Monitoring liver macrophages using nanobodies targeting Vsig4: Concanavalin A induced acute hepatitis as paradigm","volume":"220","author":"Zheng","year":"2015","journal-title":"Immunobiology"},{"key":"key20180107211517_b7-or-35-01-0307","doi-asserted-by":"crossref","first-page":"10110","DOI":"10.1021\/jf503188c","article-title":"Protective effect of ellagic acid on concanavalin A-induced hepatitis via toll-like receptor and mitogen-activated protein kinase\/nuclear factor \u03baB signaling pathways","volume":"62","author":"Lee","year":"2014","journal-title":"J Agric Food Chem"},{"key":"key20180107211517_b8-or-35-01-0307","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.intimp.2011.11.005","article-title":"Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression","volume":"12","author":"Tu","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"key20180107211517_b9-or-35-01-0307","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.immunol.25.022106.141647","article-title":"Resolution phase of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways","volume":"25","author":"Serhan","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"key20180107211517_b10-or-35-01-0307","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1182\/blood-2014-09-600593","article-title":"Resolvin(g) innate immunodeficiencies?","volume":"124","author":"Chiocchetti","year":"2014","journal-title":"Blood"},{"key":"key20180107211517_b11-or-35-01-0307","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3892\/etm.2014.1641","article-title":"Resolvin E1 reduces hepatic fibrosis in mice with Schistosoma japonicum infection","volume":"7","author":"Qiu","year":"2014","journal-title":"Exp Ther Med"},{"key":"key20180107211517_b12-or-35-01-0307","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1615\/CritRevImmunol.2014009982","article-title":"The role of polyunsaturated \u03c9-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) in bone preservation","volume":"34","author":"Gyurko","year":"2014","journal-title":"Crit Rev Immunol"},{"key":"key20180107211517_b13-or-35-01-0307","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.21347","article-title":"Global challenges in liver disease","volume":"44","author":"Williams","year":"2006","journal-title":"Hepatology"},{"key":"key20180107211517_b14-or-35-01-0307","unstructured":"UK National Statisticshttp:\/\/www.statistics.gov.uk\/"},{"key":"key20180107211517_b15-or-35-01-0307","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/516S8a","article-title":"Fatty liver disease: The liver labyrinth","volume":"516","author":"Morgan","year":"2014","journal-title":"Nature"},{"key":"key20180107211517_b16-or-35-01-0307","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrgastro.2014.203","article-title":"NAFLD: Obeticholic acid for the treatment of fatty liver disease - NASH no more?","volume":"12","author":"Ray","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20180107211517_b17-or-35-01-0307","doi-asserted-by":"crossref","first-page":"14172","DOI":"10.3748\/wjg.v20.i39.14172","article-title":"Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"20","author":"Kelley","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20180107211517_b18-or-35-01-0307","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J Hepatol"},{"key":"key20180107211517_b19-or-35-01-0307","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2012.00257","article-title":"Resolution of inflammation in obesity-induced liver disease","volume":"3","author":"Rius","year":"2012","journal-title":"Front Immunol"},{"key":"key20180107211517_b20-or-35-01-0307","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/cyto.2002.1948","article-title":"Cytokine expression in three mouse models of experimental hepatitis","volume":"19","author":"Sass","year":"2002","journal-title":"Cytokine"},{"key":"key20180107211517_b21-or-35-01-0307","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejphar.2013.09.058","article-title":"Fenofibrate A peroxisome proliferator activated receptor-\u03b1 agonist treatment ameliorates Concanavalin A-induced hepatitis in rats","volume":"721","author":"Mohamed","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"key20180107211517_b22-or-35-01-0307","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.intimp.2014.10.021","article-title":"NF-\u03baB activation and proinflammatory cytokines mediated protective effect of Indigofera caerulea Roxb on CCl4 induced liver damage in rats","volume":"23","author":"Ponmari","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"key20180107211517_b23-or-35-01-0307","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.26069","article-title":"Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytes","volume":"57","author":"Sahin","year":"2013","journal-title":"Hepatology"},{"key":"key20180107211517_b24-or-35-01-0307","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1111\/bph.12626","article-title":"Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-\u03baB and AP-1 activity in human liver cancer cells","volume":"171","author":"Hsieh","year":"2014","journal-title":"Br J Pharmacol"},{"key":"key20180107211517_b25-or-35-01-0307","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cmet.2013.11.018","article-title":"Regulation of steatohepatitis and PPAR\u03b3 signaling by distinct AP-1 dimers","volume":"19","author":"Hasenfuss","year":"2014","journal-title":"Cell Metab"},{"key":"key20180107211517_b26-or-35-01-0307","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/08923973.2012.680065","article-title":"NCPP treatment alleviates ConA-induced hepatitis via reducing CD4+T activation and NO production","volume":"34","author":"Liu","year":"2012","journal-title":"Immunopharmacol Immunotoxicol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.4389\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T16:15:33Z","timestamp":1515341733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.4389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,3]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,3]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.3892\/or.2015.4389"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.4389","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,3]]}}}